503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
21.52%
Similar revenue growth to CRWV's 23.55%. Walter Schloss would investigate if similar growth reflects similar quality.
78.69%
Cost growth above 1.5x CRWV's 19.16%. Michael Burry would check for structural cost disadvantages.
13.08%
Gross profit growth 50-75% of CRWV's 25.15%. Martin Whitman would scrutinize competitive position.
-6.95%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
5.02%
R&D change of 5.02% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
-32.69%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
38.25%
Marketing expense growth less than half of CRWV's 248.84%. David Dodd would verify if efficiency advantage is sustainable.
No Data
No Data available this quarter, please select a different quarter.
11.23%
Operating expenses growth 50-75% of CRWV's 17.97%. Bruce Berkowitz would examine efficiency.
26.08%
Total costs growth 1.25-1.5x CRWV's 18.28%. Martin Whitman would scrutinize control.
No Data
No Data available this quarter, please select a different quarter.
-1.28%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
15.10%
EBITDA growth below 50% of CRWV's 33.05%. Michael Burry would check for structural issues.
-3.88%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
15.10%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
-5.28%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
-5.14%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
12.85%
Pre-tax income growth 1.25-1.5x CRWV's 9.63%. Bruce Berkowitz would examine sustainability.
-7.13%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
5.17%
Tax expense growth 1.25-1.5x CRWV's 3.78%. Martin Whitman would scrutinize strategy.
16.30%
Net income growth exceeding 1.5x CRWV's 7.67%. David Dodd would verify competitive advantages.
-4.29%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
20.69%
Similar EPS growth to CRWV's 23.08%. Walter Schloss would investigate industry trends.
17.24%
Diluted EPS growth 50-75% of CRWV's 23.08%. Martin Whitman would scrutinize operations.
-1.27%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-1.24%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.